Alice Park

Alice Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer's disease, mental health, HIV, CRISPR, and advances in gene therapy, among other issues in health and science. She also covers the Olympics, and co-chaired TIME's inaugural TIME 100 Health Summit in 2019. Her work has won awards from the New York Press Club, and recognition from the Deadline Club. In addition, she is the author of The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives.

Recent Articles

What to Know About Compounded Versions of Weight Loss Drugs

You can get versions of Wegovy and Ozempic from a compounding pharmacy. But that doesn't necessarily mean you should.

By Alice Park

Rebound Infections Occur in 20% of Paxlovid Users

According to a new study, one in five people who take Paxlovid to treat COVID-19 end up having a rebound infection.

By Alice Park

Weight Loss Drug Wegovy Can Also Reduce Risk of Heart Events

There is new evidence that semaglutide can also help reduce the risk of dying from heart disease in some patients.

By Alice Park

FDA Approves Most Potent Weight Loss Drug Yet

Zepbound, made by Eli Lilly, is the newest FDA-approved drug for weight loss. (It was previously a diabetes treatment known as Mounjaro.)

By Alice Park

Tracking Viruses Over the Holiday Travel Season

With holiday travel about to start, CDC is expanding its airport surveillance program beyond COVID-19 to include flu and RSV.

By Alice Park

The True Story Behind 'Nyad'

The swimming feat depicted in Netflix's 'Nyad' has generated a divisive debate in the marathon swimming community.

By Alice Park

What to Know About the RSV Treatment Shortage

Not all babies might get an RSV drug this season, but there are other ways to protect them,

By Alice Park

Why Diagnosing Alzheimer’s Early Is So Important

New data from Eli Lilly and Eisai show that their Alzheimer's drugs are more effective when started earlier in the disease progression.

By Alice Park

Why Do Infants Seem to Avoid Severe COVID-19?

They aren’t immune, but serious illness is rarer among very young infants than among adults.

By Alice Park

Bed Bugs Aren’t Just a Problem In Paris

Bed bugs have an intimate relationship with humankind, and our behaviors have as much to do with infestations as anything.

By Alice Park

Weight-Loss Drugs Come With Serious GI Side Effects

Weight-loss drugs like Ozempic and Wegovy come with the risk of serious gastrointestinal issues, including inflammation in the pancreas.

By Alice Park

Nobel Prize Awarded to mRNA Pioneers

Katalin Kariko and Drew Weissman discovered a key step toward making mRNA vaccines, leading to the COVID-19 vaccine and the Nobel Prize.

By Alice Park

Does It Matter Which COVID-19 Booster Shot You Get?

With a new booster available, it’s time to look at whether switching up your shots makes a difference in your immunity.

By Alice Park

Is It Flu, COVID-19, or RSV?

At-home testing is becoming a thing not just for COVID-19, but for seasonal flu and other infections. Here's what you need to know.

By Alice Park

Wastewater Will Now Track Opioid Trends

A wastewater surveillance company is expanding its program to track opioids in sewage.

By Alice Park

What to Know About the New COVID-19 Vaccine

The CDC recommends most people should get the updated COVID-19 vaccine, especially as hospitalizations from infections increase.

By Alice Park

Too Many Mothers Are Dying in Childbirth

The Gates Foundation's 2023 Goalkeepers report proposes ways to prevent maternal and newborn deaths, even in wealthy countries.

By Alice Park

COVID-19 Is Mutating In Deer

A new study reports why COVID-19 viruses living in deer could come back to haunt humans.

By Alice Park

Moderna Says Its New COVID-19 Vaccine Works For BA.2.86

The vaccine wasn’t designed to target this latest variant, but still prompts a strong immune response, the company reports.

By Alice Park

The Lyme Genes Responsible for Severe Symptoms

Researchers report the most comprehensive genetic analysis yet of the Lyme bacterium, Borrelia burgdorferi—setting up new test possibilities.

By Alice Park
More from TIME
More From TIME